These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23234258)

  • 1. Mammographic screening debate on study design: a need to move the field forward.
    Ursin G
    BMC Med; 2012 Dec; 10():164. PubMed ID: 23234258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review.
    Tabar L; Chen TH; Hsu CY; Wu WY; Yen AM; Chen SL; Chiu SY; Fann JC; Beckmann K; Smith RA; Duffy SW
    J Med Screen; 2017 Mar; 24(1):27-33. PubMed ID: 27098311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammographic density and breast cancer screening.
    Bell RJ
    Climacteric; 2020 Oct; 23(5):460-465. PubMed ID: 32643449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discussing the benefits and harms of screening mammography.
    Brennan M; Houssami N
    Maturitas; 2016 Oct; 92():150-153. PubMed ID: 27621253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.
    Bailey SL; Sigal BM; Plevritis SK
    J Natl Cancer Inst; 2010 Aug; 102(16):1263-71. PubMed ID: 20664027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.
    Monticciolo DL; Newell MS; Hendrick RE; Helvie MA; Moy L; Monsees B; Kopans DB; Eby PR; Sickles EA
    J Am Coll Radiol; 2017 Sep; 14(9):1137-1143. PubMed ID: 28648873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of mammographic screening with and without clinical breast examination.
    Hamashima C; Ohta K; Kasahara Y; Katayama T; Nakayama T; Honjo S; Ohnuki K
    Cancer Sci; 2015 Jul; 106(7):812-8. PubMed ID: 25959787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of mammography examination in asymptomatic women.
    Kolade-Yunusa HO; Itanyi UD
    Ann Afr Med; 2021; 20(1):52-58. PubMed ID: 33727513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' attitudes and behaviour toward screening mammography in women 40 to 49 years of age.
    Smith P; Hum S; Kakzanov V; Del Giudice ME; Heisey R
    Can Fam Physician; 2012 Sep; 58(9):e508-13. PubMed ID: 22972742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic features and breast cancer risk: effects with time, age, and menopause status.
    Byrne C; Schairer C; Wolfe J; Parekh N; Salane M; Brinton LA; Hoover R; Haile R
    J Natl Cancer Inst; 1995 Nov; 87(21):1622-9. PubMed ID: 7563205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
    Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
    Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening: evidence of benefit depends on the method used.
    Autier P; Boniol M
    BMC Med; 2012 Dec; 10():163. PubMed ID: 23234249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Canadian National Breast Screening Study: a critical review.
    Kopans DB; Feig SA
    AJR Am J Roentgenol; 1993 Oct; 161(4):755-60. PubMed ID: 8372752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mammographic density as indicator of breast cancer risk].
    Ursin G
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3373-6. PubMed ID: 14713971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic screening in older women. Is it worthwhile?
    van Dijck JA; Broeders MJ; Verbeek AL
    Drugs Aging; 1997 Feb; 10(2):69-79. PubMed ID: 9061265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.